Literature DB >> 8398646

Activated C3 (C3b) in the nephritic glomerulus.

C Pan1, C F Strife, A J McAdams, C D West.   

Abstract

An autoradiographic technique was developed to assess in the nephritic glomerulus the relative amount of C3 which is in the activated form, C3b, compared with the inactivated form, iC3b. Frozen renal biopsy sections from children and young adults with glomerulonephritis were assessed for the C3b fraction of total C3, using a radiolabeled monoclonal anti-C3c. Grain counts with this antibody, before and after reacting the section with 0.0002% trypsin, gave the relative amounts of total C3 and C3b, respectively. C3b was found in all diseases studied. To explain its presence, glomerular C3b acceptors which would restrict C3b inactivation were sought by immunofluorescence studies. C3b acceptor candidates were: IgG in aggregated form, IgA as found in the IgA nephropathies and the C3/C5 convertase, C4b,2a,3b. In acute post-streptococcal glomerulonephritis and membranoproliferative glomerulonephritis type III, diseases in which these acceptors were lacking, it is postulated that the nephritis strain-associated protein and absence of membrane cofactor protein, respectively, may be responsible for C3b deposition. The phlogistic effect of C3b is mediated largely by one of its products, C5b-9. However, the C3b: total C3 ratio failed to correlate with indices of glomerular inflammation, probably in part because the ratio is not a measure of total glomerular C3b.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398646     DOI: 10.1007/bf00857544

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

Review 1.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA.

Authors:  M W Russell; B Mansa
Journal:  Scand J Immunol       Date:  1989-08       Impact factor: 3.487

3.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

5.  Localization of decay accelerating factor in normal and diseased kidneys.

Authors:  F G Cosio; D D Sedmak; J D Mahan; N S Nahman
Journal:  Kidney Int       Date:  1989-07       Impact factor: 10.612

6.  Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.

Authors:  T Seya; L L Ballard; N S Bora; V Kumar; W Cui; J P Atkinson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

7.  Kidney biopsy in SLE. I. A clinical-morphologic evaluation.

Authors:  D D Gladman; M B Urowitz; E Cole; S Ritchie; C H Chang; J Churg
Journal:  Q J Med       Date:  1989-12

8.  Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.

Authors:  W S Varade; J Forristal; C D West
Journal:  Am J Kidney Dis       Date:  1990-09       Impact factor: 8.860

9.  Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.

Authors:  R G Medicus; J Melamed; M A Arnaout
Journal:  Eur J Immunol       Date:  1983-06       Impact factor: 5.532

10.  Localization of receptors for activated complement on visceral epithelial cells of the human renal glomerulus.

Authors:  M L Shin; M C Gelfand; R B Nagle; J R Carlo; I Green; M M Frank
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.